Shares in Value put out update on PIQ as a high conviction buy up to $1.40 and to sell over $8. They see current delay of Sonic in USA as no big deal - when it launches it will rocket multiples of current price. Of course there are the other tests in pipeline as well. The latest info re the current test also being suitable for Diabetes 1 sufferers (which make up 10% of all Diabetes sufferers) will be icing on the cake. No adjustments required to current established test. Great buying opportunity IMO.
Ann: Annual Report to shareholders, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.015(4.17%) |
Mkt cap ! $61.32M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 36.0¢ | $12.40K | 33.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 104381 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 3883 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |